What is Medwise.ai?
Medwise.ai operates as a sophisticated medical information platform, specifically engineered to streamline workflows for clinicians across more than 2000 NHS organizations. By integrating research capabilities, drug information databases, and automated writing assistance, the platform serves as a comprehensive digital assistant for healthcare professionals. Originating from the Mount Sinai Elementa Labs program, the company leverages high-fidelity data to enhance clinical decision-making, thereby reducing administrative burden and improving patient outcomes. Its presence on both Android and iOS platforms ensures that critical medical intelligence is accessible in real-time, marking a significant shift toward mobile-first clinical support systems.
How much funding has Medwise.ai raised?
Medwise.ai has raised a total of $1.2M across 1 funding round:
Angel/Seed
$1.2M
Angel/Seed (2023): $1.2M with participation from Yorkshire Asset Finance
Key Investors in Medwise.ai
Yorkshire Asset Finance
Yorkshire Asset Finance Ltd is a specialized financial services firm operating within the credit cards and transaction processing industry, providing strategic capital to support enterprise growth.
What's next for Medwise.ai?
With this major strategic investment, Medwise.ai is poised to accelerate its enterprise-level expansion. The company is expected to focus on deepening its integration within the NHS ecosystem, potentially scaling its AI-driven features to address more complex diagnostic support requirements. As the firm transitions from its initial development phase into a period of rapid scaling, the focus will likely shift toward interoperability with existing electronic health record systems and expanding its footprint beyond the UK market. This capital infusion provides the necessary runway to refine its proprietary algorithms and solidify its position as a leader in the medical information technology sector.
See full Medwise.ai company page
